Search

Issue Volume 175(2022)Supplement 1

2. A composite prognostic model for overall survival (OS) based on residual cancer burden (RCB) and tumor-infiltrating lymphocytes (TILs) on residual disease (RCB+TIL) in HER2+ breast cancer patients treated with neoadjuvant therapy: a multicenter study. (November 2022)

Authors:
Miglietta, F.; Ragazzi, M.; Fernandes, B.; Griguolo, G.; Massa, D.; Bisagni, A.; Bottosso, M.; Porra, F.; Gaudio, M.; Iannaccone, D.; Fassan, M.; Lo Mele, M.; Gasparini, E.; Zarrilli, G.; Coiro, S.; Dore, L.; Zambelli, A.; Bisagni, G.; Guarneri, V.; Dieci, M.V.
Journal:
European journal of cancer
Issue:
Volume 175(2022)Supplement 1
Page Start:
S3
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. A higher number of HSP70 positive immune cells in a deep layer of TNBC is associated with a higher FOXP3 expression and a higher risk of axillary lymph node involvement. (November 2022)

Authors:
Car Peterko, A.; Rajković Molek, K.; Gulic, T.; Veljković Vujaklija, D.; Valković Zujić, P.; Belac Lovasić, I.; Lovasić, F.; Mustać, E.; Avirović, M.
Journal:
European journal of cancer
Issue:
Volume 175(2022)Supplement 1
Page Start:
S80
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. A machine learning (ML) approach for identifying genetic biomarkers and new targets associated with impaired survival of breast cancer patients. (November 2022)

Authors:
Sanz Martin, G.; Doldan Martelli, V.; Del Castillo Izquierdo, J.; Gomez del Campo, P.; Galmarini, C.M.; Domínguez Correa, J.M.
Journal:
European journal of cancer
Issue:
Volume 175(2022)Supplement 1
Page Start:
S82
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. A multimodal approach for the management of co-morbid cardiotoxicity in the elderly breast cancer patients. (November 2022)

Authors:
Karanasiou, G.; Grigoriadis, G.; Alexandraki, A.; Antoniades, A.; Brown, C.; Bucur, A.; Cipolla, C.; Economopoulou, P.; Foukakis, T.; Goossens, J.; Keramida, K.; Lakkas, L.; Marias, K.; Naka, K.; Papakonstantinou, A.; Pravettoni, G.; Ribnikar, D.; Šeruga, B.; Zacharia, M.; Tsiknakis, M.
Journal:
European journal of cancer
Issue:
Volume 175(2022)Supplement 1
Page Start:
S40
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. A novel biomarker to predict DNA-Repair-inhibitor response in stage I-III high risk breast cancer patients. (November 2022)

Authors:
Barcaru, A.; Kuilman, M.M.; Wolf, D.; Yau, C.; Choy, E.B.M.; Audeh, W.M.; Brown-Swigart, L.; Hirst, G.L.; Symmans, F.W.; Liu, M.C.; Nanda, R.; Esserman, L.J.; van 't Veer, L.J.; Glas, A.M.; Mittempergher, L.
Journal:
European journal of cancer
Issue:
Volume 175(2022)Supplement 1
Page Start:
S79
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. A Phase III, Randomized, Multicenter, Double-blind Study to Compare Efficacy and Safety of EG12014 (EirGenix Trastuzumab) with Herceptin® as Neoadjuvant Treatment in Combination with Anthracycline/Paclitaxel-based Systemic Therapy in Patients with HER2-positive Early Breast Cancer. (November 2022)

Authors:
Henneberg, J.; Grohmann-Izay, B.; Huang, C.S.; Schulze, C.; Llinas, N.; Giorgi, D.; Misra, A.; Pominchuk, D.; Prokhorof, A.; Rapoport, B.; Semiglazov, V.; Tseng, L.M.; Yanez Ruiz, E.; Loibl, S.
Journal:
European journal of cancer
Issue:
Volume 175(2022)Supplement 1
Page Start:
S60
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search